These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 11135065)

  • 1. The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.
    Lager DJ; Qian Q; Bengal RJ; Ishibashi M; Torres VE
    Kidney Int; 2001 Jan; 59(1):126-36. PubMed ID: 11135065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease.
    Zoja C; Corna D; Locatelli M; Rottoli D; Pezzotta A; Morigi M; Zanchi C; Buelli S; Guglielmotti A; Perico N; Remuzzi A; Remuzzi G
    Nephron; 2015; 129(1):52-61. PubMed ID: 25531096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-Related Alterations in Blood Biochemical Characterization of Hepatorenal Function in the PCK Rat: A Model of Polycystic Kidney Disease.
    Shimomura Y; Brock WJ; Ito Y; Morishita K
    Int J Toxicol; 2015; 34(6):479-90. PubMed ID: 26503599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic kidney rat is a novel animal model of Caroli's disease associated with congenital hepatic fibrosis.
    Sanzen T; Harada K; Yasoshima M; Kawamura Y; Ishibashi M; Nakanuma Y
    Am J Pathol; 2001 May; 158(5):1605-12. PubMed ID: 11337358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease.
    Yoshihara D; Kugita M; Sasaki M; Horie S; Nakanishi K; Abe T; Aukema HM; Yamaguchi T; Nagao S
    PLoS One; 2013; 8(12):e81480. PubMed ID: 24324698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease.
    Togawa H; Nakanishi K; Mukaiyama H; Hama T; Shima Y; Sako M; Miyajima M; Nozu K; Nishii K; Nagao S; Takahashi H; Iijima K; Yoshikawa N
    Am J Physiol Renal Physiol; 2011 Feb; 300(2):F511-20. PubMed ID: 21084407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a Vasopressin V2 Receptor Antagonist on Polycystic Kidney Disease Development in a Rat Model.
    Wang X; Constans MM; Chebib FT; Torres VE; Pellegrini L
    Am J Nephrol; 2019; 49(6):487-493. PubMed ID: 31117065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease.
    Wang X; Harris PC; Somlo S; Batlle D; Torres VE
    Nephrol Dial Transplant; 2009 Feb; 24(2):526-34. PubMed ID: 18826972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal-dominant polycystic kidney disease in the rat.
    Cowley BD; Gudapaty S; Kraybill AL; Barash BD; Harding MA; Calvet JP; Gattone VH
    Kidney Int; 1993 Mar; 43(3):522-34. PubMed ID: 8455352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine autosomal recessive polycystic kidney disease with multiorgan involvement induced by the cpk gene.
    Gattone VH; MacNaughton KA; Kraybill AL
    Anat Rec; 1996 Jul; 245(3):488-99. PubMed ID: 8800407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azotemia and extrarenal manifestations in old female Han:SPRD (cy/+) rats.
    Kränzlin B; Schieren G; Gretz N
    Kidney Int; 1997 Apr; 51(4):1160-9. PubMed ID: 9083282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insignificant effect of secretin in rodent models of polycystic kidney and liver disease.
    Wang X; Ye H; Ward CJ; Chu JY; Masyuk TV; Larusso NF; Harris PC; Chow BK; Torres VE
    Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1089-98. PubMed ID: 22811488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic kidney disease in Sprague-Dawley rats.
    Shoieb A; Shirai N
    Exp Toxicol Pathol; 2015; 67(5-6):361-4. PubMed ID: 25753522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary n-3 polyunsaturated fatty acids or soy protein isolate did not attenuate disease progression in a female rat model of autosomal recessive polycystic kidney disease.
    Maditz KH; Oldaker C; Nanda N; Benedito V; Livengood R; Tou JC
    Nutr Res; 2014 Jun; 34(6):526-34. PubMed ID: 25026920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease stage characterization of hepatorenal fibrocystic pathology in the PCK rat model of ARPKD.
    Mason SB; Liang Y; Sinders RM; Miller CA; Eggleston-Gulyas T; Crisler-Roberts R; Harris PC; Gattone VH
    Anat Rec (Hoboken); 2010 Aug; 293(8):1279-88. PubMed ID: 20665806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney disease.
    Muchatuta MN; Gattone VH; Witzmann FA; Blazer-Yost BL
    Exp Biol Med (Maywood); 2009 Jan; 234(1):17-27. PubMed ID: 18997107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib.
    Sato Y; Harada K; Furubo S; Kizawa K; Sanzen T; Yasoshima M; Ozaki S; Isse K; Sasaki M; Nakanuma Y
    Am J Pathol; 2006 Oct; 169(4):1238-50. PubMed ID: 17003482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Expression and Function of Hepatic Transporters in a Rodent Model of Polycystic Kidney Disease.
    Bezençon J; Beaudoin JJ; Ito K; Fu D; Roth SE; Brock WJ; Brouwer KLR
    Drug Metab Dispos; 2019 Aug; 47(8):899-906. PubMed ID: 31160314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats.
    Torres VE; Sweeney WE; Wang X; Qian Q; Harris PC; Frost P; Avner ED
    Kidney Int; 2004 Nov; 66(5):1766-73. PubMed ID: 15496147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.